In vivo and in vitro data have shown that the activation of the AhR signaling pathway can inhibit the growth and/or migration of breast cancer (Tao et al., 2011), pancreatic cancer (Jin et al., 2018), and ovarian cancer (Wang et al., 2013). Here, AHR is linked to breast carcinoma.